Maintenance therapy of multiple myeloma: is there a best drug or combinations ?
10.3760/cma.j.issn.1009-9921.2017.12.005
- VernacularTitle:多发性骨髓瘤的维持治疗:有最佳药物或药物组合吗?
- Author:
Hujun LI
1
;
Zhenyu LI
;
Kailin XU
Author Information
1. 221002,徐州医科大学附属医院血液科
- Keywords:
Multiple myeloma;
Maintenance therapy;
Minimal residual disease;
Immunomodulator;
Protease inhibitor
- From:
Journal of Leukemia & Lymphoma
2017;26(12):721-724,733
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myeloma (MM) is a kind of common hematologic neoplasms. The application of new drugs and autologous hemopoietic stem cell transplantation can significantly improve the response rate of MM. However, as it is impossible to eradicate the minimal residual disease, recurrence is unavoidable. Maintenance therapy has the potential to increase remission degree, thus lengthening the progression-free survival and overall survival time of MM patients.
